omniture
KAZIA THERAPEUTICS LIMITED.

Latest News

Cantrixil Receives Orphan Drug Designation from FDA

SYDNEY, April 22, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today announc...

2015-04-22 12:29 2201

Novogen Conducts Private Placement and Announces Rights Offering to Shareholders

SYDNEY, April 21, 2015 /PRNewswire/ -- Novogen Limited (ASX:NRT; NASDAQ:NVGN) ("Company" or "Novoge...

2015-04-21 11:34 2062

Cantrixil Highly Successful in Preventing Growth of Chemo-Resistant Ovarian Cancer

NEW YORK, April 21, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (...

2015-04-21 08:52 1793

Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer

SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today announc...

2015-04-17 09:43 2353

Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma

SYDNEY, April 9, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen (NRT:ASX; NVGN:...

2015-04-09 11:06 1800

Novogen Engages Leading US Investor Relations Firm

SYDNEY, April 2, 2015 /PRNewswire/ -- Novogen Ltd (ASX:NRT NASDAQ:NVGN) today announced it has appo...

2015-04-02 10:49 2378

Yale University and Novogen Release Data on Cantrixil Mode of Action

SYDNEY, March 30, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;...

2015-03-30 08:53 1812

Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study

SYDNEY, March 19, 2015 /PRNewswire/ -- Novogen announced on 18th March, 2015 that one of its oncolo...

2015-03-19 04:00 1885

Sky News, Helen Dalley interviews Dr Graham Kelly

SYDNEY, March 10, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN')CEO, Dr Graham K...

2015-03-10 12:28 1840

US Studies Confirm Ability of TRXE-009 to Kill Brain Cancer Stem Cells

SYDNEY, March 4, 2015 /PRNewswire/ -- Australian/US biotechnology company, Novogen Limited (ASX:NRT;...

2015-03-04 19:00 1408

Novogen to Present at AusBiotech "Broker Meets Biotech" Event

SYDNEY, March 3, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN'), an Australian-US dr...

2015-03-03 11:02 1786

Novogen to Present at SACHS Cancer Bio Partnering & Investment Forum

NEW YORK, Feb. 22, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN'), an Australian-US d...

2015-02-23 10:41 1641

Novogen Investor Briefing Well Received

NEW YORK, Feb. 19, 2015 /PRNewswire/ -- Novogen presented yesterday (Wednesday February 18) to an au...

2015-02-20 04:47 1953

Novogen to Hold Investor Briefing in New York

NEW YORK, Feb. 17, 2015 /PRNewswire/ -- Novogen is holding an Investor Briefing in New York on Wedne...

2015-02-17 19:07 1224

Novogen Lodges Key Super-benzopyran Patent

SYDNEY, Feb. 11, 2015 /PRNewswire/ -- Novogen Limited (ASX:NRT; NASDAQ:NVGN) today announced the lod...

2015-02-11 23:00 1575

Novogen to present at BIO & CEO Investor Conference 9th & 10th February, 2015

SYDNEY, Feb. 3, 2015 /PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN) is pleased to announce...

2015-02-03 23:00 1524

Novogen CEO to Present at Biotech and Money Conference in London

SYDNEY, Jan. 23, 2015 /PRNewswire/ -- Novogen (ASX: NRT; NASDAQ: NVGN), an Australian-US drug disco...

2015-01-23 17:00 1769

Novogen Announces Important Discovery in Regenerative Medicine Program

SYDNEY, Jan. 15, 2015 /PRNewswire/ -- Novogen Limited (ASX:NRT; NASDAQ:NVGN), an Australian/US biote...

2015-01-15 23:00 2157

Novogen Raises A$4.1m In Private Placement to US Institutions

SYDNEY, Dec. 17, 2014 /PRNewswire/ -- Novogen Limited (ASX:NRT; NASDAQ:NVGN): Australian/US biotechn...

2014-12-17 23:00 1459

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

SYDNEY, Dec. 16, 2014 /PRNewswire/ -- Novogen Limited (ASX:NRT; NASDAQ:NVGN), Australian/US biotechn...

2014-12-16 23:00 1339